Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 in Children With Recurrent Wheezing
NCT05857930Phase 2Completed
- Sponsor
- OM Pharma
- Start
- Jun 2023
- Primary completion
- Sep 2026
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of OM-85 in wheeze, sponsored by OM Pharma. Started Jun 2023; status: completed.
02
Drugs
OM-85
03
Conditions
wheeze
Beyond the preview
Go deeper on NCT05857930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05857930.